Efficient Drug Development

TNO works with public and private parties to create and implement innovative technologies that make the process of drug development – from laboratory to patient – more efficient. This will make it possible to cut development costs and to get drugs to patients sooner.

Do you want to exchange knowledge?

Steven Erpelinck is happy to talk to you.

Our latest developments

22 resultaten, getoond 1 t/m 5

Obesity

Informatietype:
Article
Advance obesity drug development with TNO’s translational Ldlr−/−.Leiden mouse model. Generate clinically relevant, multi-organ efficacy data with AI-supported analysis that closely aligns with human outcomes.

Diabetic kidney disease

Informatietype:
Article

Liver (MASLD-MASH and liver fibrosis)

Informatietype:
Article

HistoSuite: AI-powered histopathology

Informatietype:
Article

Spatial Mass Spectrometry

Informatietype:
Article